- Home
- DGNX vs BLFS Comparison
DGNX vs BLFS Comparison
Compare DGNX & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGNX
- BLFS
- Stock Information
- Founded
- DGNX 2018
- BLFS 1987
- Country
- DGNX United Kingdom
- BLFS United States
- Employees
- DGNX N/A
- BLFS N/A
- Industry
- DGNX
- BLFS Medical/Dental Instruments
- Sector
- DGNX
- BLFS Health Care
- Exchange
- DGNX NYSE
- BLFS Nasdaq
- Market Cap
- DGNX 1.2B
- BLFS 1.2B
- IPO Year
- DGNX 2025
- BLFS 1989
- Fundamental
- Price
- DGNX $57.51
- BLFS $22.36
- Analyst Decision
- DGNX
- BLFS Strong Buy
- Analyst Count
- DGNX 0
- BLFS 7
- Target Price
- DGNX N/A
- BLFS $30.57
- AVG Volume (30 Days)
- DGNX 37.7K
- BLFS 567.8K
- Earning Date
- DGNX 01-01-0001
- BLFS 05-08-2025
- Dividend Yield
- DGNX N/A
- BLFS N/A
- EPS Growth
- DGNX N/A
- BLFS N/A
- EPS
- DGNX N/A
- BLFS N/A
- Revenue
- DGNX $1,177,066.00
- BLFS $82,254,000.00
- Revenue This Year
- DGNX N/A
- BLFS $20.32
- Revenue Next Year
- DGNX N/A
- BLFS $19.98
- P/E Ratio
- DGNX N/A
- BLFS N/A
- Revenue Growth
- DGNX N/A
- BLFS 8.44
- 52 Week Low
- DGNX $3.60
- BLFS $17.15
- 52 Week High
- DGNX $155.00
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- DGNX N/A
- BLFS 45.11
- Support Level
- DGNX N/A
- BLFS $21.13
- Resistance Level
- DGNX N/A
- BLFS $25.60
- Average True Range (ATR)
- DGNX 0.00
- BLFS 1.36
- MACD
- DGNX 0.00
- BLFS -0.11
- Stochastic Oscillator
- DGNX 0.00
- BLFS 31.65
About DGNX DIGINEX LIMITED
Diginex Ltd is an investment holding company. It engaged in providing Environmental, Social, and Governance (ESG) reporting solution services, advisory services, and developing customization solutions.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.